Diagnosis and management of pemphigus: Recommendations of an
international panel of experts

J 2020

Diagnosis and management of pemphigus: Recommendations of an international panel of experts

MURRELL, D. F.; S. PENA; P. JOLY; B. MARINOVIC; T. HASHIMOTO et al.

Základní údaje

Originální název

Diagnosis and management of pemphigus: Recommendations of an international panel of experts

Autoři

MURRELL, D. F.; S. PENA; P. JOLY; B. MARINOVIC; T. HASHIMOTO; L. A. DIAZ; A. A. SINHA; A. S. PAYNE; M. DANESHPAZHOOH; R. EMING; M. F. JONKMAN; D. MIMOUNI; L. BORRADORI; S. C. KIM; J. YAMAGAMI; J. S. LEHMAN; M. A. SALEH; D. A. CULTON; A. CZERNIK; J. J. ZONE; D. FIVENSON; H. UJIIE; K. WOZNIAK; A. AKMAN-KARAKAS; P. BERNARD; N. J. KORMAN; F. CAUX; K. DRENOVSKA; C. PROST-SQUARCIONI; S. VASSILEVA; R. J. FELDMAN; A. R. CARDONES; J. BAUER; D. IOANNIDES; Hana JEDLIČKOVÁ; F. PALISSON; A. PATSATSI; S. UZUN; S. YAYLI; D. ZILLIKENS; M. AMAGAI; M. HERTL; E. SCHMIDT; V. AOKI; S. A. GRANDO; H. SHIMIZU; S. BAUM; G. CIANCHINI; C. FELICIANI; P. IRANZO; J. M. MASCARO; C. KOWALEWSKI; R. HALL; R. GROVES; K. E. HARMAN; M. P. MARINKOVICH; E. MAVERAKIS a V. P. WERTH

Vydání

JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, NEW YORK, MOSBY-ELSEVIER, 2020, 0190-9622

Další údaje

Jazyk

angličtina

Typ výsledku

Článek v odborném periodiku

Obor

30216 Dermatology and venereal diseases

Stát vydavatele

Spojené státy

Utajení

není předmětem státního či obchodního tajemství

Odkazy

URL

Impakt faktor

Impact factor: 11.527

Označené pro přenos do RIV

Ano

Kód RIV

RIV/00216224:14110/20:00116159

Organizační jednotka

Lékařská fakulta

Klíčová slova anglicky

CD20 inhibitor; consensus; guidelines; pemphigus foliaceus; pemphigus vulgaris; treatment

Štítky

14110125, rivok

Příznaky

Mezinárodní význam, Recenzováno

Změněno: 31. 8. 2020 11:22, Mgr. Tereza Miškechová

Anotace

V originále

Background: Several European countries recently developed international diagnostic and management guidelines for pemphigus, which have been instrumental in the standardization of pemphigus management. Objective: We now present results from a subsequent Delphi consensus to broaden the generalizability of the recommendations. Methods: A preliminary survey, based on the European Dermatology Forum and the European Academy of Dermatology and Venereology guidelines, was sent to a panel of international experts to determine the level of consensus. The results were discussed at the International Bullous Diseases Consensus Group in March 2016 during the annual American Academy of Dermatology conference. Following the meeting, a second survey was sent to more experts to achieve greater international consensus. Results: The 39 experts participated in the first round of the Delphi survey, and 54 experts from 21 countries completed the second round. The number of statements in the survey was reduced from 175 topics in Delphi I to 24 topics in Delphi II on the basis of Delphi results and meeting discussion. Limitations: Each recommendation represents the majority opinion and therefore may not reflect all possible treatment options available. Conclusions: We present here the recommendations resulting from this Delphi process. This international consensus includes intravenous CD20 inhibitors as a first-line therapy option for moderate-to-severe pemphigus.

Citovat

@article{1673726,
   author = {Murrell, D. F. and Pena, S. and Joly, P. and Marinovic, B. and Hashimoto, T. and Diaz, L. A. and Sinha, A. A. and Payne, A. S. and Daneshpazhooh, M. and Eming, R. and Jonkman, M. F. and Mimouni, D. and Borradori, L. and Kim, S. C. and Yamagami, J. and Lehman, J. S. and Saleh, M. A. and Culton, D. A. and Czernik, A. and Zone, J. J. and Fivenson, D. and Ujiie, H. and Wozniak, K. and AkmanandKarakas, A. and Bernard, P. and Korman, N. J. and Caux, F. and Drenovska, K. and ProstandSquarcioni, C. and Vassileva, S. and Feldman, R. J. and Cardones, A. R. and Bauer, J. and Ioannides, D. and Jedličková, Hana and Palisson, F. and Patsatsi, A. and Uzun, S. and Yayli, S. and Zillikens, D. and Amagai, M. and Hertl, M. and Schmidt, E. and Aoki, V. and Grando, S. A. and Shimizu, H. and Baum, S. and Cianchini, G. and Feliciani, C. and Iranzo, P. and Mascaro, J. M. and Kowalewski, C. and Hall, R. and Groves, R. and Harman, K. E. and Marinkovich, M. P. and Maverakis, E. and Werth, V. P.},
   article_location = {NEW YORK},
   article_number = {3},
   doi = {https://doi.org/10.1016/j.jaad.2018.02.021},
   keywords = {CD20 inhibitor; consensus; guidelines; pemphigus foliaceus; pemphigus vulgaris; treatment},
   language = {eng},
   issn = {0190-9622},
   journal = {JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY},
   title = {Diagnosis and management of pemphigus: Recommendations of an international panel of experts},
   url = {https://www.sciencedirect.com/science/article/pii/S019096221830207X},
   volume = {82},
   year = {2020}
}

TY  - JOUR
ID  - 1673726
AU  - Murrell, D. F. - Pena, S. - Joly, P. - Marinovic, B. - Hashimoto, T. - Diaz, L. A. - Sinha, A. A. - Payne, A. S. - Daneshpazhooh, M. - Eming, R. - Jonkman, M. F. - Mimouni, D. - Borradori, L. - Kim, S. C. - Yamagami, J. - Lehman, J. S. - Saleh, M. A. - Culton, D. A. - Czernik, A. - Zone, J. J. - Fivenson, D. - Ujiie, H. - Wozniak, K. - Akman-Karakas, A. - Bernard, P. - Korman, N. J. - Caux, F. - Drenovska, K. - Prost-Squarcioni, C. - Vassileva, S. - Feldman, R. J. - Cardones, A. R. - Bauer, J. - Ioannides, D. - Jedličková, Hana - Palisson, F. - Patsatsi, A. - Uzun, S. - Yayli, S. - Zillikens, D. - Amagai, M. - Hertl, M. - Schmidt, E. - Aoki, V. - Grando, S. A. - Shimizu, H. - Baum, S. - Cianchini, G. - Feliciani, C. - Iranzo, P. - Mascaro, J. M. - Kowalewski, C. - Hall, R. - Groves, R. - Harman, K. E. - Marinkovich, M. P. - Maverakis, E. - Werth, V. P.
PY  - 2020
TI  - Diagnosis and management of pemphigus: Recommendations of an international panel of experts
JF  - JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
VL  - 82
IS  - 3
SP  - "575"-"585.e1"
EP  - "575"-"585.e1"
PB  - MOSBY-ELSEVIER
SN  - 01909622
KW  - CD20 inhibitor
KW  - consensus
KW  - guidelines
KW  - pemphigus foliaceus
KW  - pemphigus vulgaris
KW  - treatment
UR  - https://www.sciencedirect.com/science/article/pii/S019096221830207X
L2  - https://www.sciencedirect.com/science/article/pii/S019096221830207X
N2  - Background: Several European countries recently developed international diagnostic and management guidelines for pemphigus, which have been instrumental in the standardization of pemphigus management. Objective: We now present results from a subsequent Delphi consensus to broaden the generalizability of the recommendations. Methods: A preliminary survey, based on the European Dermatology Forum and the European Academy of Dermatology and Venereology guidelines, was sent to a panel of international experts to determine the level of consensus. The results were discussed at the International Bullous Diseases Consensus Group in March 2016 during the annual American Academy of Dermatology conference. Following the meeting, a second survey was sent to more experts to achieve greater international consensus. Results: The 39 experts participated in the first round of the Delphi survey, and 54 experts from 21 countries completed the second round. The number of statements in the survey was reduced from 175 topics in Delphi I to 24 topics in Delphi II on the basis of Delphi results and meeting discussion. Limitations: Each recommendation represents the majority opinion and therefore may not reflect all possible treatment options available. Conclusions: We present here the recommendations resulting from this Delphi process. This international consensus includes intravenous CD20 inhibitors as a first-line therapy option for moderate-to-severe pemphigus.
ER  -

Přehled o publikaci